Infugen Pharma Private Limited, a active private limited company, was established on 04 February 1999 in Sangli, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231PN1999PTC013295. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.00 M.
Formerly known as Jeshika Pharma Private Limited. It upholds a compliant status. Its leadership includes Sandeep Jagjeevan Modi (Director), Bharat Jagjivan Bhate (Director). It holds ₹20.10 Cr open charges and ₹1.60 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Yashokamalharbhat Road Opp Sangli Urban Co-Op Bank Ltd, Sangli, Maharashtra, 416416.
U24231PN1999PTC013295
013295
04 February 1999
₹3.00 M
₹1.00 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Infugen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandeep Jagjeevan Modi | Director | 04 Feb 1999 | Current |
| Bharat Jagjivan Bhate | Director | 04 Feb 1999 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Infugen Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.25% increase. The company also saw a substantial improvement in profitability, with a 145.9% increase in profit. The company's net worth Soared by an impressive increase of 51.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Infugen Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹201,000,000.00
₹16,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 2025 | Others | ₹1.00 Cr | Open |
| 30 Dec 2021 | Others | ₹1.35 Cr | Open |
| 28 Sep 2020 | Others | ₹10.00 Cr | Open |
| 19 Mar 2020 | Others | ₹3.50 Cr | Open |
| 20 Mar 2012 | Others | ₹4.25 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Infugen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Infugen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infugen Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 100.00 M registered on 28 Sep 2020 with Charge ID 100385297 was modified on 11 Sep 2025. was completed.
Progress on A charge with Others amounted to Rs. 10.00 M with Charge ID 101099753 was registered on 21 May 2025. was documented.
The activity Infugen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge registered on 02 Aug 2017 via Charge ID 100115665 with Others was fully satisfied on 24 Apr 2024. was recorded as a recent event.
A charge registered on 01 Sep 2004 via Charge ID 80061619 with Sangli Urban Co-Operative Bank Limited was fully satisfied on 24 Apr 2024. was recorded as a recent event.
Progress on A charge with Others of Rs. 35.00 M registered on 19 Mar 2020 with Charge ID 100335510 was modified on 06 Apr 2024. was documented.
The CIN of Infugen Pharma Private Limited is U24231PN1999PTC013295.
Infugen Pharma Private Limited is headquartered at Yashokamalharbhat Road Opp Sangli Urban Co-Op Bank Ltd, Sangli, Maharashtra, 416416.
Infugen Pharma Private Limited was incorporated on 04 February 1999.
The current directors of Infugen Pharma Private Limited are
The primary industry of Infugen Pharma Private Limited is Trade.
Infugen Pharma Private Limited is unlisted.
The authorized capital of Infugen Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Infugen Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX